ANDROGEN REPLACEMENT

Course overview

TESTOSTERONE IS FDA-APPROVED AS REPLACEMENT THERAPY IN MEN WHO HAVE LOW TESTOSTERONE LEVELS AND THOSE WITH SYMPTOMS OF HYPOGONADISM. IT IS ESSENTIAL TO DISTINGUISH BETWEEN PRIMARY (TESTICULAR) AND SECONDARY (PITUITARY-HYPOTHALAMIC) HYPOGONADISM. THIS ACTIVITY REVIEWS THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT TO MEMBERS OF THE INTERPROFESSIONAL TEAM TO USE EXOGENOUS TESTOSTERONE TO TREAT HYPOGONADISM.